Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

302 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Efficacy of Polymer-Free Drug-Eluting Stents.
Chiarito M, Sardella G, Colombo A, Briguori C, Testa L, Bedogni F, Fabbiocchi F, Paggi A, Palloshi A, Tamburino C, Margonato A, Pivato CA, Baber U, Calcagno S, Giordano A, Godino C, Stefanini GG. Chiarito M, et al. Among authors: sardella g. Circ Cardiovasc Interv. 2019 Feb;12(2):e007311. doi: 10.1161/CIRCINTERVENTIONS.118.007311. Circ Cardiovasc Interv. 2019. PMID: 30767663
A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial.
Biondi-Zoccai GG, Valgimigli M, Sheiban I, Margheri M, Marzocchi A, Prati F, Vischi M, Lettieri C, Violini R, Sardella G, Stabile A, Clementi F, Romeo F, Colombo A, Sangiorgi G. Biondi-Zoccai GG, et al. Among authors: sardella g. J Cardiovasc Med (Hagerstown). 2008 Sep;9(9):957-62. doi: 10.2459/JCM.0b013e3282ffd3a6. J Cardiovasc Med (Hagerstown). 2008. PMID: 18695440 Clinical Trial.
Angiographic and clinical outcome of invasively managed patients with thrombosed coronary bare metal or drug-eluting stents: the OPTIMIST study.
Burzotta F, Parma A, Pristipino C, Manzoli A, Belloni F, Sardella G, Rigattieri S, Danesi A, Mazzarotto P, Summaria F, Romagnoli E, Prati F, Trani C, Crea F. Burzotta F, et al. Among authors: sardella g. Eur Heart J. 2008 Dec;29(24):3011-21. doi: 10.1093/eurheartj/ehn479. Epub 2008 Nov 5. Eur Heart J. 2008. PMID: 18987096
Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: results from the 4,314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS).
Romagnoli E, De Servi S, Tamburino C, Colombo A, Burzotta F, Presbitero P, Bolognese L, Paloscia L, Rubino P, Sardella G, Briguori C, Ettori F, Franco G, Di Girolamo D, Sheiban I, Piatti L, Greco C, Petronio S, Loi B, Lioy E, Benassi A, Patti A, Gaspardone A, Capodanno D, Biondi-Zoccai GG, Sangiorgi G; I-BIGIS Study Group Milan, Italy. Romagnoli E, et al. Among authors: sardella g. Am Heart J. 2010 Sep;160(3):535-542.e1. doi: 10.1016/j.ahj.2010.06.028. Am Heart J. 2010. PMID: 20826264
Impact of drug-eluting stents and diabetes mellitus in patients with coronary bifurcation lesions: a survey from the Italian Society of Invasive Cardiology.
Capodanno D, Tamburino C, Sangiorgi GM, Romagnoli E, Colombo A, Burzotta F, Gasparini GL, Bolognese L, Paloscia L, Rubino P, Sardella G, Briguori C, Ettori F, Franco G, Di Girolamo D, Sheiban I, Piatti L, Greco C, Petronio AS, Loi B, Lyoi E, Benassi A, Patti A, Gaspardone A, De Servi S; I-BIGIS Study Group. Capodanno D, et al. Among authors: sardella g. Circ Cardiovasc Interv. 2011 Feb 1;4(1):72-9. doi: 10.1161/CIRCINTERVENTIONS.110.959460. Epub 2011 Jan 4. Circ Cardiovasc Interv. 2011. PMID: 21205940
302 results